You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,074,668


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,074,668
Title: Container for an inhalation anesthetic
Abstract:A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polyethylene napthalate. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Inventor(s): Flament-Garcia; Mary Jane (Gurnee, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Garapolo; Joan (Libertyville, IL), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Ramsay; George M. (Waukegan, IL), Rice; Patrick (Waukegan, IL), Setesak; Jeffrey (Lincolnshire, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:09/004,876
Patent Claim Types:
see list of patent claims
Compound; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,074,668

To delve into the details of the scope and claims of United States Patent 6,074,668, it is essential to analyze the patent document itself, as well as the broader patent landscape and relevant guidelines.

Patent Overview

United States Patent 6,074,668, though not specifically detailed in the provided sources, typically involves a detailed description of the invention, its background, and the claims that define the scope of the patent.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, as they define the scope of protection. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[4].

Claim Types

  • Independent Claims: These claims define the invention without reference to other claims. They are crucial as they set the broadest scope of protection.
  • Dependent Claims: These claims refer back to an independent claim and narrow down the scope by adding additional limitations.

Claim Interpretation

The interpretation of claims is critical in determining the patent's scope. This involves understanding the language used, the context, and any limitations or exceptions mentioned in the claims.

Patent Eligibility and Scope

Subject Matter Eligibility

The USPTO's 2024 guidance update on AI patents highlights the importance of subject matter eligibility. For a patent to be eligible, it must integrate a judicial exception into a practical application, showing meaningful limits on the exception and transforming the claim into patent-eligible subject matter[1].

Practical Applications

Claims must demonstrate a practical application to be considered patent-eligible. For example, in the context of AI, claims that apply AI to solve specific technical problems, such as speech signal processing or medical treatment personalization, can be patent-eligible if they provide concrete benefits[1].

Patent Landscape and Prior Art

Searching Prior Art

To understand the scope of a patent, it is crucial to search prior art. The USPTO provides several tools for this, including the Patent Public Search tool, Global Dossier, and access to international patent databases[4].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and prior art[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by multiple offices for the same invention, helping to identify relevant prior art and assess the novelty and non-obviousness of the claimed invention[4].

Economic and Statistical Context

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications, which can be used to analyze trends and scope measurements. This dataset includes claim-level statistics and document-level statistics, offering insights into patent scope and claims structure[3].

Recent Case Law and Guidance

Integration of Recent Case Law

The 2024 USPTO guidance update incorporates recent Federal Circuit decisions, ensuring that the application of patent eligibility criteria is consistent with the latest judicial thinking. This integration helps in drafting claims that are more likely to avoid section 101 rejections[1].

Examples and Claims Analysis

The guidance includes new examples specifically tailored to AI technologies, such as Example 48, which illustrates how claims involving AI-based methods for analyzing speech signals can be patent-eligible by demonstrating an improvement in computer technology and providing a practical application[1].

Drafting Patent-Eligible Claims

Meaningful Limits and Practical Applications

Claims must include meaningful limits and integrate judicial exceptions into practical applications. For instance, Claim 2 in Example 48 specifies the use of separated audio components in a speech recognition system, which adds a level of practical utility and makes the claim patent-eligible[1].

Avoiding Abstract Ideas

Claims should avoid being mere abstract ideas by specifying how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. This is crucial in demonstrating that the claimed invention offers a concrete technological improvement[1].

International Patent Landscape

Searching International Databases

To ensure global novelty and non-obviousness, it is essential to search international patent databases, such as those provided by the European Patent Office, Japan Patent Office, and World Intellectual Property Organization[4].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications: Claims should demonstrate concrete benefits and solve specific technical problems.
  • Prior Art Search: Thoroughly search prior art using tools like the Patent Public Search and Global Dossier.
  • Recent Case Law: Ensure claims align with the latest judicial interpretations and guidance updates.
  • International Landscape: Search international patent databases to assess global novelty and non-obviousness.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing more tools for evaluating patentability and drafting claims that avoid common rejections.

How do AI-assisted inventions impact patent eligibility?

The method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring AI-assisted inventions are evaluated on equal footing with other technologies.

What role do practical applications play in patent eligibility?

Practical applications are crucial as they transform abstract ideas into patent-eligible subject matter by demonstrating concrete benefits and solving specific technical problems.

How can one ensure claims are patent-eligible in the context of AI?

Ensure claims integrate judicial exceptions into practical applications, specify meaningful limits, and demonstrate concrete technological improvements, as illustrated in the new examples provided by the USPTO guidance update.

What resources are available for searching prior art?

Resources include the USPTO's Patent Public Search tool, Global Dossier, Common Citation Document (CCD), and international patent databases such as those from the European Patent Office and World Intellectual Property Organization.

Citations

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. Ex Parte Swinson et al - Casetext.
  3. Patent Claims Research Dataset - USPTO.
  4. Search for patents - USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,074,668

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,074,668

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 019364 ⤷  Subscribe
Austria 237295 ⤷  Subscribe
Australia 2110999 ⤷  Subscribe
Australia 732187 ⤷  Subscribe
Bulgaria 104672 ⤷  Subscribe
Bulgaria 64142 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.